[{"Assets_0_Q1_USD":258688000.0,"CommonStockSharesOutstanding_0_Q1_shares":41380000.0,"EarningsPerShareBasic_1_Q1_USD":0.63,"EarningsPerShareDiluted_1_Q1_USD":0.61,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":25308000.0,"NetIncomeLoss_1_Q1_USD":25910000.0,"StockholdersEquity_0_Q1_USD":59082000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":42810000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":41374000.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170510"}]